We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Cannabidiol as an Adjunctive Treatment for Bipolar Depression (CBDBD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03310593
Recruitment Status : Terminated (It was interrupted due to the coronavirus pandemic outbreak.)
First Posted : October 16, 2017
Last Update Posted : July 2, 2021
Federal University of Rio Grande do Sul
University of Sao Paulo
Information provided by (Responsible Party):
Hospital de Clinicas de Porto Alegre

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : February 24, 2020
Actual Study Completion Date : March 24, 2020